Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab: A consensus statement of the Working Party on Haemostasis of the Swiss Society of Haematology and the Swiss Haemophilia Network. Swiss Medical Weekly, [S. l.], v. 150, n. 5153, p. w20422, 2020. DOI: 10.4414/smw.2020.20422. Disponível em: https://www.smw.ch/index.php/smw/article/view/2933. Acesso em: 14 oct. 2025.